Search research articles
Contact Us
Filters
Showing results (11-20 of 552) with videos related to
Page
of 56
Sort By:
Breast Cancer Research : BCR
|
December 22, 2010
Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry
Britta Weigelt, Jorge S Reis-Filho
Journal of the National Cancer Institute
|
August 14, 2014
Back to the basis: breast cancer heterogeneity from an etiological perspective
Britta Weigelt, Jorge S Reis-Filho
The Journal of Pathology
|
October 10, 2013
Epistatic interactions and drug response
Britta Weigelt, Jorge S Reis-Filho
Cancer Discovery
|
February 13, 2013
Activating mutations in HER2: neu opportunities and neu challenges
Britta Weigelt, Jorge S Reis-Filho
Breast Cancer Research : BCR
|
October 29, 2003
The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions
Jorge S Reis-Filho, Sunil R Lakhani
The Lancet. Oncology
|
April 4, 2012
Genetic heterogeneity and cancer drug resistance
Nicholas C Turner, Jorge S Reis-Filho
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2005
Ewing's sarcoma of the rectum: can we afford not to use molecular pathology?
Jean-Yves Pierga, Jorge S Reis-Filho
Genes, Chromosomes & Cancer
|
December 11, 2012
The 11q13-q14 amplicon: clinicopathological correlations and potential drivers
Paul M Wilkerson, Jorge S Reis-Filho
JAMA Oncology
|
December 15, 2022
Clinical Trials and Digital Pathology-Toward Quantitative Therapeutic Immunohistochemistry and Tissue Hybridization
Manuel Salto-Tellez, Jorge S Reis-Filho
Journal of Clinical Pathology
|
November 29, 2007
Non-operative breast pathology
Sarah E Pinder, Jorge S Reis-Filho
Page
of 56
Search research articles
Search
Showing results (11-20 of 552) with videos related to
Sort By:
Page
of 56
Breast Cancer Research : BCR
|
December 22, 2010
Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry
Britta Weigelt, Jorge S Reis-Filho
Journal of the National Cancer Institute
|
August 14, 2014
Back to the basis: breast cancer heterogeneity from an etiological perspective
Britta Weigelt, Jorge S Reis-Filho
The Journal of Pathology
|
October 10, 2013
Epistatic interactions and drug response
Britta Weigelt, Jorge S Reis-Filho
Cancer Discovery
|
February 13, 2013
Activating mutations in HER2: neu opportunities and neu challenges
Britta Weigelt, Jorge S Reis-Filho
Breast Cancer Research : BCR
|
October 29, 2003
The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions
Jorge S Reis-Filho, Sunil R Lakhani
The Lancet. Oncology
|
April 4, 2012
Genetic heterogeneity and cancer drug resistance
Nicholas C Turner, Jorge S Reis-Filho
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2005
Ewing's sarcoma of the rectum: can we afford not to use molecular pathology?
Jean-Yves Pierga, Jorge S Reis-Filho
Genes, Chromosomes & Cancer
|
December 11, 2012
The 11q13-q14 amplicon: clinicopathological correlations and potential drivers
Paul M Wilkerson, Jorge S Reis-Filho
JAMA Oncology
|
December 15, 2022
Clinical Trials and Digital Pathology-Toward Quantitative Therapeutic Immunohistochemistry and Tissue Hybridization
Manuel Salto-Tellez, Jorge S Reis-Filho
Journal of Clinical Pathology
|
November 29, 2007
Non-operative breast pathology
Sarah E Pinder, Jorge S Reis-Filho
Page
of 56